Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.
Centessa 2.0 with a twist: Medicxi combines six immuno-derm startups with $100M
European biotech investor Medicxi is bringing six startups under one roof to form an immuno-dermatology drugmaker with 14 pipeline projects in a move reminiscent of